收藏切换
The molecular mechanism of stroke treatment by Fufang Longmai Ningfang based on network pharmacology
收藏切换
PDF
Xia SHEN1, Dan REN1, Jing GAO1, *, Gang ZHANG1, Yong-hua WANG2, *, Liang PENG1, Li-shan PEI1
Acta Pharmaceutica Sinica | 2019, 54(9) : 1588 - 1596
Less
收藏切换
Acta Pharmaceutica Sinica | 2019, 54(9): 1588-1596
Original Articles
The molecular mechanism of stroke treatment by Fufang Longmai Ningfang based on network pharmacology
Full
Xia SHEN1, Dan REN1, Jing GAO1, *, Gang ZHANG1, Yong-hua WANG2, *, Liang PENG1, Li-shan PEI1
Affiliations
  • 1. School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, China
  • 2. Northwest University, Xi'an 710069, China
Published: 2019-09-12 doi: 10.16438/j.0513-4870.2019-0031
Outline
收藏切换

Stroke is a common disease with complex and diverse clinical manifestations. Fufang Longmai Ningfang has been found to exhibit therapeutic effect on stroke, but its molecular mechanism for treating stroke remains unclear. The aim of this study was to investigate the molecular mechanism of Fufang Longmai Ningfang in the treatment of ischemic stroke by using the method of network pharmacology to define the active ingredients, target and molecular pathway of Fufang Longmai Ningfang. The TCMSP database was used to obtain the potential active components of Fufang Longmai Ningfang in the treatment of stroke. The CNKI database was used to verify the literature. The target was predicted and screened by PharmMapper and UniProt database. The target protein group was collected by TTD database. The Cytoscape software was used to construct a "component-target" network map, "component-target-disease" network map, and "target protein interaction" network map. The EAGLE algorithm was used for cluster analysis, the KEGG database was used for pathway analysis, and the SYBYL software was used for molecular docking for bioactivity verification. We found 39 potential active ingredients and 17 potential effective targets related to stroke. The representative active ingredients were ligustrazine, dioscin, and puerarin, and the related targets were MMP9, NOS3, NOS2, KDR, ALB, IL2, TGFB2, and CPB among others. The study found that carbon metabolism and HIF-1 signaling pathway are the main molecular pathways for treatment of stroke by Fufang Longmai Ningfang. The treatment of ischemic stroke by Fufang Longmai Ningfang may involve reduction of inflammatory response, enhancement of vascular permeability and inhibition of cerebral ischemia-reperfusion injury, providing a theoretical basis for their clinical use.

network pharmacology  /  Fufang Longmai Ningfang  /  stroke  /  ischemic stroke  /  target
Xia SHEN, Dan REN, Jing GAO, Gang ZHANG, Yong-hua WANG, Liang PENG, Li-shan PEI. The molecular mechanism of stroke treatment by Fufang Longmai Ningfang based on network pharmacology[J]. Acta Pharmaceutica Sinica, 2019 , 54 (9) : 1588 -1596 . DOI: 10.16438/j.0513-4870.2019-0031
Year 2019 volume 54 Issue 9
PDF
130
56
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2019-0031
  • Receive Date:2019-01-09
  • Online Date:2026-01-26
  • Published:2019-09-12
Article Data
Affiliations
History
  • Received:2019-01-09
  • Revised:2019-02-11
Funding
Affiliations
    1. School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, China
    2. Northwest University, Xi'an 710069, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2019-0031
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT